1887
Rapid communications Open Access
Like 0

Abstract

Neisseria gonorrhoeae has developed resistance to most of the available therapeutic antimicrobials. The susceptibility to extended-spectrum cephalosporins, the last remaining first-line treatment option, is decreasing globally. This report describes the first two cases outside Japan of verified gonorrhoea clinical failures using internationally recommended first-line cefixime treatment. Enhanced awareness and more frequent follow-up examination, test-of-cure and appropriate verification/falsification of presumed clinical treatment failures, involving several clinical and laboratory parameters should be strongly emphasised worldwide.

Loading

Article metrics loading...

/content/10.2807/ese.15.47.19721-en
2010-11-25
2017-11-19
http://instance.metastore.ingenta.com/content/10.2807/ese.15.47.19721-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/15/47/art19721-en.htm?itemId=/content/10.2807/ese.15.47.19721-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error